Vivos Therapeutics, Inc. (VVOS)
0.70
+0.03
(+4.48%)
USD |
NASDAQ |
May 29, 16:00
0.70
0.00 (0.00%)
After-Hours: 20:00
Vivos Therapeutics EPS Diluted (Quarterly) : -0.5249 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Hinge Health, Inc. | 0.3119 |
| Exlites Holdings International, Inc. | -0.0004 |
| Xcelerate, Inc. | 0.00 |
| Abbott Laboratories | 0.6165 |
| AngioDynamics, Inc. | -0.1944 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.751M |
| Revenue (Quarterly) | 5.141M |
| Total Expenses (Quarterly) | 12.82M |
| Enterprise Value | 19.76M |
| Gross Profit Margin (Quarterly) | 50.67% |
| Profit Margin (Quarterly) | -150.8% |
| Earnings Yield | -330.2% |
| Normalized Earnings Yield | -330.21 |